Equities

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LKMNH.E:IST

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS

Actions
Health CareHealth Care Providers
  • Price (TRY)15.72
  • Today's Change-0.14 / -0.88%
  • Shares traded1.41m
  • 1 Year change-19.18%
  • Beta0.7014
Data delayed at least 15 minutes, as of Mar 03 2026 15:09 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS (Lokman Hekim) is a Turkey-based company active in the healthcare sector. It operates two hospitals as of January 18, 2011. The Company opened its first hospital in Etlik, Ankara, in 2002, and its second hospital in Sincan in 2008. The departments in the two hospitals include emergency service, neurosurgery, dietetic, gynecology, rehabilitation, urology, orthopedics and cardiology, among others.

  • Revenue in TRY (TTM)4.05bn
  • Net income in TRY142.62m
  • Incorporated1996
  • Employees2.43k
  • Location
    Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut ASZubeyde Hanim Mah. Aslanbey Cad. No:17IskitlerANKARA 06070TurkeyTUR
  • Phone+90 3 124449911
  • Fax+90 3 123316779
  • Websitehttps://lokmanhekim.com.tr
More ▼

Institutional shareholders

1.10%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 05 Feb 20262.16m1.00%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025172.93k0.08%
DFA Australia Ltd.as of 31 Jan 202637.97k0.02%
American Century Investment Management, Inc.as of 05 Feb 20264.10k0.00%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.